Original document(17 pages)  中文版
    Programmed release tablets, to be administered by oral route, containing from 500 to 1,200 mg of naproxen, made by mixtures of an immediate release granulate dry compacted containing from 5% to 28% of naproxen, of a controlled release granulate dry compacted containing from 72% to 95% of naproxen and of a disintegrating agent. A portion of naproxen is released in a short time, so that the drug can quickly develop its therapeutic action reaching the necessary hematic levels, while the remaining portion is released in a longer interval of time, so as to allow the therapeutic coverage till the subsequent administration. The therapeutic coverage is effective for a period of 24 hours; thus the tablets object of the present invention are suitable for a once a day administration.
Application Number
申请号
93116664 Application Date
申请日
1993.09.08
Title 名称 Programmed release tablets containing naproxen
Publication Number
公开号
1088091 Publication Date
公开日
1994.06.22
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K9/22;A61K9/26;A61K47/26;A61K47/30
Applicant(s) Name
申请人
Alfa Wassermann S.p.A.
Address 地址
Inventor(s) Name 发明人 Egidio Marchi;Leone Gabriele Rotini
Attorney & Agent 代理人 HUANG GESHENG

  
Man and wife health washing preparation
Personal cleanser with moisturizer
Skin growth hormone-containing cosmetics and preparing method thereof
Beauty and massage elastomer and its making method
Health preparation for skin care
Preparing process of skin-caring milk and its products
Foot-odor removing spray agent
Process for preparing filter membrane wrapped and decocted Chinese drug preparation
Magneto-thermal massage physiotherapy instrument
Multi-functional intelligent hospital bed with bedpan
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.